Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

Key Points Non-GAAP earnings per share (EPS) of $2.25 in Q2 2025 far surpassed the analyst estimate of $0.32 and rose 923% year-over-year compared to Q2 2024 (non-GAAP adjusted diluted EPS per ADS).

Discover BeOne Medicines' robust Q2 2025 performance, with 42% revenue growth, market leadership in oncology, and raised 2025 guidance.

Pyaar Kaanoon Dhokha Season 2 will premiere on September 19. Kajol will return as Noyonika Sengupta in the new season.

For more than 10 years, Netsmart has been at the forefront of interoperability efforts, advocating for improved standards like the sharing of behavioral health and substance use data that meet the ...

In the second quarter of 2025, Myriad Genetics initiated a review of its long-range growth strategy. While the updated strategy, which is designed to drive accelerated growth and profitability by ...

CCLD READ THE FULL CCLD RESEARCH REPORT Pre-market open on 8/5/25, CareCloud (NASDAQ:CCLD) reported 2Q25 earnings results. For the quarter, CCLD reported GAAP net income of $2.9 million – the ...

As the United States market navigates a complex landscape of tariff concerns and economic uncertainties, major indices like the Dow Jones and S&P 500 have experienced fluctuations with recent rallies ...

Q2 2025 Management View Stephen A. Snyder, Co-CEO, reported a pivotal quarter for CareCloud, highlighting positive momentum in AI-driven innovation, operational discipline, and sustainable growth.

Specialty RCM Adoption Surges as Providers Seek Automated Solutions to Rising Claim Complexity, Regulatory Pressure and ...

CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of healthcare technology and generative AI solutions, today announced that its electronic health record (“EHR”) ...